Scientific Chair: Mustafa Nuri Yenerel (İstanbul University, Turkey) Mustafa Çetiner (Koç University, İstanbul) |
Title |
Presenter Name |
A Novel Marker CD317 in Patients with CD34 Negative B-Cell Acute Lymphoblastic Leukemia |
Zehra Narli Ozdemir |
Whole Genome Expression Profiling at Diagnosis Predicts Relapse in Childhood Acute Lymphoblastic Leukemia |
Khusan Khodzhaev |
Comparıson Of Consolıdatıon Strategıes in Acute Myeloıd Leukemıa: Standard Chemotherapy Vs Autologous Hematopoıetıc Stem Cell Transplantatıon |
Asena Dikyar |
Post Remission Treatment Score for Predicting the Survival in Acute Myeloid Leukemia : Single Centre Experience |
Elifcan Aladag |
Long Term Follow up of Idiopathic Cytopenia of Undetermined Significance (ICUS), Clonal Cytopenia of Undetermined Significance (CCUS) Towards Myelodysplastic Syndrome (MDS) |
Elif Gülsüm Ümit |
Determination of Therapeutic Potential of Luteolin for Acute Lymphoblastic Leukemia Cells |
Sevim Beyza Gürler |
|
Scientific Chair: Taner Demirer (Ankara University, Turkey), Levent Ündar (Akdeniz University, Turkey) |
Title |
Presenter Name |
Exosomal Dna From Plasma Of Patıents Wıth Dlbcl: Comparıson Dna Methylatıon Patterns Of Ezh2-Target Genes Of Exosomes And Matchıng Prımary Tumor Tıssue |
İkbal Cansu Barış |
Retrospective Analysis of 149 Unselected Patients with Mantle Cell Lymphoma Confirms Prognostic Relevance of MIPI: Single Center Experience |
Güldane Cengiz Seval |
Leukapheresis Reduces 4-Week Mortality in Acute Myeloid Leukemia Patients with Hyperleukocytosis – a Retrospective Study from a Tertiary Center |
Güldane Cengiz Seval |
Hodgkın Lymphoma In The Elderly: A Retrospectıve Multıcenter Study By Turkısh Socıety Of Hematology, Lymphoma Academy |
Olga Meltem Akay |
Circulating MicroRNA-125a as a Potential Serum Biomarker for Diffuse Large B-Cell Lymphoma |
Mohammad Ahmadvand |
The Correlatıon Between Interım Imagıng Results and Dısease Prognosıs of Patients with Hodgkın and Dıffuse Large B Cell Lymphoma: Sıngle Center Experıence |
Esra Erpek |
|
Scientific Chair: Tülin Tuğlular( Marmara University, Turkey), Jelana Bila(University of Belgrade, Serbia) |
Title |
Presenter Name |
Myth or Reality? The Frequency and Significance of Double Hit or Triple Hit Multiple Myeloma at a Single Center in Northwestern Turkey |
Mehmet Baysal |
The Comparıson of The Relatıonshıp Between Polyneuropathy Frequency and Clınıcal and Laboratory Fındıngs in Multıple Myeloma Cases |
Aysun Senturk Yikilmaz |
Pre-Transplant Hemoglobin and Serum Creatinine Levels Correlate with Progression Free Survival in Myeloma Patients Undergoing Autologous Stem Cell Transplantation |
Guldane Cengiz Seval |
Retrospective Evaluation of Immunomudulatory Agents Response and Side Effects in Relapsed Refractoy Myeloma Patients: Real Life Experience |
Yaşa Gül Mutlu |
Collection of Stem Cells ≥ 5.0 x 10e6/of Body Weight in One Day in Multiple Myeloma in The Process of Autologous Stem Cell Transplantation |
Alma Sofo Hafizovic |
Can Autologous Stem Cell Transplantation Abrogate The Poor Prognosis Associated with High LDH? |
Guldane Cengiz Seval |
|
Scientific Cahir: Hannan Hamed(Ain Shams University, Cairo), Ahmad Ibrahim(Arab University, Beirut) |
Title |
Presenter Name |
An Adaptive Phenotypic Shift Leads to TKI Resistance by Acquisition of Leukemic Stem Cell-Like Properties in CML Cells |
Zeynep Yüce |
Long Noncodıng Rna Hotaır is a New Potentıal Bıomarker for Chronıc Myeloıd Leukemıa (Cml) Not for Acute Myeloıd Leukemıa (Aml) in Turkısh Patıents |
Esma Bentli |
Vancomycın Resıstant Enterococcı Colonızatıon, Predısposıng Factors for Infectıon and Prognostıc Factors in Patıents wıth Febrıle Neutropenıa |
Tugcan Alp Kırkızlar |
Epıdemıology of Chronıc Myeloıd Leukemıa in Azerbaıjan |
Chingiz Asadov |
Which Markers Should the Used for Chronic Lymphocytic Leukemia Scoring System by Immunophenotyping ? |
Mehmet Sezgin Pepeler |
Mersin University Last Decade Experience with Myelofibrosis |
Berrin Balık Aydın |